Guidance for industry : ANDAs, impurities in drug substances.

Guidance for industry : ANDAs, impurities in drug substances.

Bibliographic Details
Corporate Author: Center for Drug Evaluation and Research (U.S.). Office of Generic Drugs
Format: Government Document eBook
Language:English
Published: Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2009]
Subjects:
Drug adulteration > Government policy > United States.
Drug approval > United States.
Online Access:https://purl.fdlp.gov/GPO/LPS117047

Similar Items